BMJ India has teamed up with Fortis C-DOC Centre of Excellence for Diabetes, Metabolic Diseases & Endocrinology in New Delhi to provide educational support for health professionals to improve care for people with diabetes in India.
India has the second highest number of diabetics in the world, at about 65 million, after China, and this figure is likely to reach 80 million by 2030.
And the first phase of the India diabetes (INDIAB) study, shows that seven out of 10 diabetics in India – especially those in the 20-24 age group – do not take enough steps to control their blood sugar level – even after diagnosis.
In this context it becomes essential that there are educational initiatives that aid the healthcare community in clinical diagnosis and management of diabetes.
The diabetes course will meet these challenges by helping physicians improve their knowledge of diabetes, its diagnosis and management. The course is delivered online, with a structured contact programme.
Patrick Spencer, Chief Operating Officer, BMJ said: “With the prevalence of diabetes being so high in India, the importance of raising awareness about prevention and regular screening for timely detection, especially among young people, is vital.”
Prashant Mishra, Managing Director, BMJ India, said: “We are delighted to be involved in this initiative to help doctors learn more about this condition and really make a difference to diabetes care across the country.”
Dr Anoop Misra, Chairman, Fortis C-DOC said: “We are proud to be associated with BMJ in starting diabetes certification course which should match similar courses anywhere in the world. A quality education regarding diabetes for Indian doctors will go a long way to curb the epidemic of diabetes and its complications in India.”
For more information, please write to firstname.lastname@example.org